Cleared Traditional

K243152 - GelPOINT V-Path Transvaginal Access Platform with Retroperitoneal Access Device (FDA 510(k) Clearance)

Oct 2025
Decision
367d
Days
Class 2
Risk

K243152 is an FDA 510(k) clearance for the GelPOINT V-Path Transvaginal Access Platform with Retroperitoneal Access Device. This device is classified as a Culdoscope (and Accessories) (Class II - Special Controls, product code HEW).

Submitted by Applied Medical Resources Corp. (Rancho Santa, US). The FDA issued a Cleared decision on October 2, 2025, 367 days after receiving the submission on September 30, 2024.

This device falls under the Obstetrics & Gynecology FDA review panel. Regulated under 21 CFR 884.1640.

Submission Details

510(k) Number K243152 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2024
Decision Date October 02, 2025
Days to Decision 367 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF

Device Classification

Product Code HEW — Culdoscope (and Accessories)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 884.1640